Integrin inhibitors are therapeutic agents designed to block the interaction between integrins and the ECM. By inhibiting these interactions, integrin inhibitors can potentially halt cancer cell migration, invasion, and other processes critical for tumor growth and metastasis. These inhibitors can be small molecules, monoclonal antibodies, or peptides that target specific integrin subunits.
